CN117431261A - OfDrosha gene dsRNA capable of improving termite control effect of Serratia marcescens - Google Patents
OfDrosha gene dsRNA capable of improving termite control effect of Serratia marcescens Download PDFInfo
- Publication number
- CN117431261A CN117431261A CN202311496611.5A CN202311496611A CN117431261A CN 117431261 A CN117431261 A CN 117431261A CN 202311496611 A CN202311496611 A CN 202311496611A CN 117431261 A CN117431261 A CN 117431261A
- Authority
- CN
- China
- Prior art keywords
- ofdrosha
- dsrna
- gene
- termite
- serratia marcescens
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000256602 Isoptera Species 0.000 title claims abstract description 60
- 108091032973 (ribonucleotides)n+m Proteins 0.000 title claims abstract description 50
- 102000040650 (ribonucleotides)n+m Human genes 0.000 title claims abstract description 41
- 241000607715 Serratia marcescens Species 0.000 title claims abstract description 23
- 230000000694 effects Effects 0.000 title claims abstract description 19
- 108090000623 proteins and genes Proteins 0.000 title claims description 47
- 238000000034 method Methods 0.000 claims abstract description 21
- 239000002689 soil Substances 0.000 claims abstract description 20
- 241000894006 Bacteria Species 0.000 claims abstract description 9
- 239000002773 nucleotide Substances 0.000 claims abstract description 7
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 7
- 241000607720 Serratia Species 0.000 claims abstract 2
- 241001509990 Rhinotermitidae Species 0.000 claims description 35
- 241001387505 Heterotermes tenuis Species 0.000 claims description 16
- 239000012634 fragment Substances 0.000 claims description 10
- 210000004027 cell Anatomy 0.000 claims description 9
- 239000002299 complementary DNA Substances 0.000 claims description 8
- 239000013604 expression vector Substances 0.000 claims description 7
- 239000013612 plasmid Substances 0.000 claims description 7
- 241000223600 Alternaria Species 0.000 claims description 6
- 238000010367 cloning Methods 0.000 claims description 6
- 238000010839 reverse transcription Methods 0.000 claims description 5
- 238000011144 upstream manufacturing Methods 0.000 claims description 5
- 244000052616 bacterial pathogen Species 0.000 claims description 4
- 238000000246 agarose gel electrophoresis Methods 0.000 claims description 3
- 210000000170 cell membrane Anatomy 0.000 claims description 3
- 210000002421 cell wall Anatomy 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 238000009210 therapy by ultrasound Methods 0.000 claims description 3
- 241001131798 Escherichia coli HT115 Species 0.000 claims description 2
- 230000002147 killing effect Effects 0.000 claims description 2
- 230000000443 biocontrol Effects 0.000 abstract description 5
- 239000000126 substance Substances 0.000 abstract description 3
- 238000013461 design Methods 0.000 abstract description 2
- 230000001988 toxicity Effects 0.000 abstract 1
- 231100000419 toxicity Toxicity 0.000 abstract 1
- 101100144701 Mus musculus Drosha gene Proteins 0.000 description 24
- 230000014509 gene expression Effects 0.000 description 21
- 239000002609 medium Substances 0.000 description 14
- 239000007788 liquid Substances 0.000 description 11
- 230000001580 bacterial effect Effects 0.000 description 10
- 230000030279 gene silencing Effects 0.000 description 10
- 230000009368 gene silencing by RNA Effects 0.000 description 9
- 239000002679 microRNA Substances 0.000 description 9
- 241000238631 Hexapoda Species 0.000 description 8
- 238000012228 RNA interference-mediated gene silencing Methods 0.000 description 8
- 241000257303 Hymenoptera Species 0.000 description 7
- 238000011529 RT qPCR Methods 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 108700011259 MicroRNAs Proteins 0.000 description 6
- 239000004098 Tetracycline Substances 0.000 description 6
- 241000607479 Yersinia pestis Species 0.000 description 6
- 125000003275 alpha amino acid group Chemical group 0.000 description 6
- 229960000723 ampicillin Drugs 0.000 description 6
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 229960002180 tetracycline Drugs 0.000 description 6
- 229930101283 tetracycline Natural products 0.000 description 6
- 235000019364 tetracycline Nutrition 0.000 description 6
- 150000003522 tetracyclines Chemical class 0.000 description 6
- 238000012258 culturing Methods 0.000 description 5
- 238000000855 fermentation Methods 0.000 description 5
- 230000004151 fermentation Effects 0.000 description 5
- 230000002265 prevention Effects 0.000 description 5
- 230000004083 survival effect Effects 0.000 description 5
- 239000013598 vector Substances 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 4
- 230000001276 controlling effect Effects 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 102000003661 Ribonuclease III Human genes 0.000 description 3
- 108010057163 Ribonuclease III Proteins 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000010195 expression analysis Methods 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 210000003128 head Anatomy 0.000 description 3
- 230000002452 interceptive effect Effects 0.000 description 3
- 238000013081 phylogenetic analysis Methods 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 241000238659 Blatta Species 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 108700026244 Open Reading Frames Proteins 0.000 description 2
- 244000061457 Solanum nigrum Species 0.000 description 2
- 235000002594 Solanum nigrum Nutrition 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 238000000540 analysis of variance Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000013043 chemical agent Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 238000001502 gel electrophoresis Methods 0.000 description 2
- 210000000087 hemolymph Anatomy 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 108091007428 primary miRNA Proteins 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000001850 reproductive effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 238000000527 sonication Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 230000009261 transgenic effect Effects 0.000 description 2
- 230000009385 viral infection Effects 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical group OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- 102100039980 40S ribosomal protein S18 Human genes 0.000 description 1
- 241000254032 Acrididae Species 0.000 description 1
- 241001124076 Aphididae Species 0.000 description 1
- 239000004475 Arginine Chemical group 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 241000254173 Coleoptera Species 0.000 description 1
- 241001506130 Cryptotermes secundus Species 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 241000255925 Diptera Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
- 108050002220 Green fluorescent protein, GFP Proteins 0.000 description 1
- 101000811259 Homo sapiens 40S ribosomal protein S18 Proteins 0.000 description 1
- 101000869796 Homo sapiens Microprocessor complex subunit DGCR8 Proteins 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical group NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- 241000255777 Lepidoptera Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102100032459 Microprocessor complex subunit DGCR8 Human genes 0.000 description 1
- 108010089610 Nuclear Proteins Proteins 0.000 description 1
- 102000007999 Nuclear Proteins Human genes 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 241000866536 Odontotermes formosanus Species 0.000 description 1
- 241000238814 Orthoptera Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 208000035415 Reinfection Diseases 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Chemical group OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 241000964233 Zootermopsis nevadensis Species 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Chemical group OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 230000008436 biogenesis Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 238000010805 cDNA synthesis kit Methods 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000013400 design of experiment Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 235000021186 dishes Nutrition 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 230000035553 feeding performance Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
- 239000005090 green fluorescent protein Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000000749 insecticidal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 108091070501 miRNA Proteins 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 150000007523 nucleic acids Chemical group 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 230000001124 posttranscriptional effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 238000003239 susceptibility assay Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000003151 transfection method Methods 0.000 description 1
- 238000011870 unpaired t-test Methods 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases RNAses, DNAses
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/20—Bacteria; Substances produced thereby or obtained therefrom
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A01P7/00—Arthropodicides
- A01P7/04—Insecticides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/30—Special therapeutic applications
- C12N2320/32—Special delivery means, e.g. tissue-specific
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/425—Serratia
- C12R2001/43—Serratia marcescens
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Pest Control & Pesticides (AREA)
- Environmental Sciences (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Agronomy & Crop Science (AREA)
- Dentistry (AREA)
- Insects & Arthropods (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
The invention discloses a method for improving the termite control effect of Serratia marcescensOfDroshaGene dsRNA. The saidOfDroshaThe nucleotide sequence of (2) is shown as SEQ ID N0:1. The invention designs dsRNA (ds)OfDrosha) And further constructing the dsRNA-HT115 engineering strain. Dss for black wing soil termitesOfDroshaAfter treatment, thenTreatment with Serratia marcescens resulted in a significant increase in mortality, indicating dsOfDroshaThe toxicity of biocontrol bacteria is improved, and a theoretical basis is provided for further improving the biological control or chemical control effect of controlling the black wing soil termites.
Description
Technical Field
The invention relates to the technical field of biology, in particular to an OfDrosha gene dsRNA capable of improving the termite control effect of Serratia marcescens.
Background
Termites are worldwide pests, and damage involves house buildings, hydraulic dykes, pipeline facilities, agriculture, forestry, plants and the like, causing great economic losses each year. The termite Odontotermesformosanus (Shiraki) is a soil-dwelling termite belonging to the genus subterranean termite of the subfamily of the family Blatta, belonging to the order Blatta, and is one of the most serious termites harmful to agriculture and forestry plants, and can harm various crops and woods. In addition, the black wing soil termites are also important pests of the water conservancy dykes, and can cause dykes to collapse when the pests are serious. The termite is wide in distribution range, and mainly takes tree roots, cortex, seedlings, saplings, crop straws, sugarcanes, bamboo roots, grass roots, rice and the like as feeding objects, and can also feed cow dung, so that feeding performance is very miscellaneous. The black wing soil termites have different grades of differentiation in the same group due to different positions, different labor division and different levels of termite king, termite postambary, winged adults, soldier termites and industrial termites. Termite individuals can be classified into two major types, reproductive and non-reproductive, from the external morphology and physiology. The prevention and treatment means of the black wing soil termites mainly comprise physical prevention and treatment, biological prevention and treatment, chemical prevention and treatment and the like. Physical control mainly utilizes physical barriers such as gravel, waterproof films, inert powder or plastic baffles and the like to protect buildings and the like from termites. Chemical agents for controlling the black wing termites are the most dominant control means at present, but the chemical agents have great negative influence on the environment. Biological control has the advantages of being friendly to the environment and not injuring non-target organisms. But biological control has weaker control effect on termites, and the biological control effect is improved by using a biological technology, so that the termite control method is a future development trend.
RNA interference (RNAi) is a complex process of regulating gene expression under the action of various enzymes, and can trigger specific silencing of target genes by generating fragmented RNA, so that the RNA has high specificity, high efficiency and amplification effect. The basic principle of RNAi in pest control is to cause the growth and development of pests to be blocked or even to be fatal by interfering with the transcription and posttranscriptional processes of exogenous target genes. However, RNAi technology is also not the same in different insect applications. The dsRNA needs to exert RNA interference effect in cells, and methods for allowing in vitro dsRNA to enter cells mainly comprise microinjection, feeding and soaking transfection methods, and methods such as virus infection, symbiont mediation, transgenic plant mediation, nanoparticle coating, liposome modification and the like are derived on the basis of the methods. Because of the high specific targeting mechanism of dsRNA, RNAi mediated by dsRNA has a great application prospect in pest control.
Drosha, a ribonuclease of RNase III family, is a core molecule in the microRNA (miRNA) production pathway. mirnas are single stranded RNAs of 19-25 nucleotides in length produced by endogenous hairpin transcripts. The nuclear micro-processing complex consisting of Drosha and DGCR8 recognizes and cleaves a hairpin primary miRNA (pri-miRNA) to produce a precursor miRNA (pre-miRNA), which is then transferred out of the nucleus by the action of export-5 (Exp 5) and sheared by the cytoplasmic RNase III family nuclease Dicer to produce a double stranded miRNA of about 22 nucleotides. Drosha is a large nuclear protein of 130-160kDa in size, with multiple domains, which are conserved in animals. Drosha consists of three parts, namely N-terminal proline, serine and arginine rich regions, a DGCR binding region and a C-terminal region containing RNaseIII cleavage activity, wherein RNaseIII domain comprises RNaseIII Da and NaseRIIIb and a dsRBD. RNase III proteins exhibit a high degree of conservation in their basic mechanism of action. Two RNaseIII's interact to form a dimer. At the interface between the two RNaseIII's, a single treatment center was formed containing two closely spaced catalytic sites, either of which could cleave each dsRNA strand. Drosha proteins localize themselves to the nucleus by phosphorylation and form the final miRNA processing function.
Recent studies indicate that Drosha has a direct role in controlling viral infections, in addition to its classical function in miRNA biogenesis. Drosha is involved in regulating development and feeding processes of grasshopper in desert. Silencing the drosha gene of aphids increases the sensitivity of insects to plant secondary substances. The research shows that Drosha protein participates in the growth and development of insects, feeding and stress-resistant processes. At present, research on the function of the OfDrosha gene of the subterranean termite at home and abroad is not reported at home and abroad. The function of the Drosha gene of the black wing soil termite in the Serratia marcescens is clarified, so that the control effect of the biocontrol bacteria Serratia marcescens is improved, and a theoretical basis is provided for the application and popularization of the biological control of the termite.
Disclosure of Invention
The invention aims to provide a black wing soil termite gene Drosha (OfDrosha) and dsRNA thereof, and the black wing soil termite gene Drosha (OfDrosha) and dsRNA thereof are combined with Serratia marcescens (Serratia marcescens, SM 1) to control termites.
In order to achieve the above purpose, the technical scheme of the invention is as follows:
the invention provides a black wing soil termite OfDrosha gene, the nucleotide sequence of which is shown as SEQ ID N0:1.
The invention provides an application of the above-mentioned Alternaria nigromaculata OfDrosha gene in reducing the pathogenic bacteria resistance of termites.
Further, the pathogenic bacteria are Serratia marcescens.
The invention improves a black wing soil termite OfDrosha gene dsRNA, which is obtained by any black wing soil termite OfDrosha.
The invention also provides a control method of the black wing subterranean termite, which comprises the steps of obtaining dsRNA from any black wing subterranean termite ofDrosha gene, treating the black wing subterranean termite for 6-24h by using the dsRNA, and then treating the subterranean termite by using Serratia marcescens.
The invention also provides an application of the OfDrosha gene dsRNA in improving the effect of Serratia marcescens in preventing and controlling the subterranean termites, wherein the OfDrosha gene dsRNA capable of improving the effect of Serratia marcescens in preventing and controlling the subterranean termites is obtained by a nucleotide sequence shown as SEQ ID N0:1, and the preparation method of the OfDrosha gene dsRNA comprises the following steps:
(1) Extracting total RNA in the black wing soil termite body, and obtaining termite cDNA library through reverse transcription; (2) Using termite cDNA as a template, amplifying the OfDrosha gene fragment by using an OfDrosha specific primer, and separating and purifying the OfDrosha gene fragment by agarose gel electrophoresis, wherein the OfDrosha specific primer is as follows: an upstream primer (5 '-3') ATGTGGTACAATGACTCGGGAG, and a downstream primer (5 '-3') TTATTTCTTGCCTGCAGACACTT;
(3) Introducing the OfDrosha gene fragment into an expression vector L4440 by TA cloning, and detecting to obtain an OfDrosha plasmid containing the target gene OfDrosha;
(4) Using an OfDrosha plasmid as a template, and amplifying by using a specific primer to obtain a dsRNA template, wherein the sequence of the upstream primer (5 '-3') is
CCCAAGCTTGTGACCGTAGGATTCATTACATGAA, the sequence of the downstream primer (5 '-3') is CCGCTCGAGTGGTGAGATTTTGCAGCAGC;
(5) The fused expression vector is transformed into qualified cell escherichia coli HT115 (DE 3) to obtain dsRNA-HT115 engineering strain;
(6) Killing dsRNA-HT115 engineering strains by using an ultrasonic treatment method, and simultaneously destroying cell walls and cell membranes of bacteria to promote the release of dsRNA;
(7) After the dsRNA obtained above is fed to the black wing soil termites through filter paper, serratia marcescens is dripped on the chest backboard of the worker termite.
Further, after the dsRNA is treated for 6-24 hours, serratia marcescens is used for treatment.
Further, after 6 hours of treatment of the subterranean termites with the dsRNA, the subterranean termites were treated with Serratia marcescens.
The invention has the beneficial effects that:
according to the invention, dsRNA (dsOfDrosha) is designed aiming at the obtained OfDrosha of the black wing termites, and the RNAi technology is utilized to interfere and inhibit the expression quantity of the OfDrosha gene in the body of the black wing termites; the black wing subterranean termite treated by dsOfDrosha is contacted with SM1 biocontrol bacterium, the antibacterial activity and the survival rate are obviously reduced, the active immunity of the infected termite is broken, and the control effect of the SM1 biocontrol bacterium on the termite is obviously improved. The invention can be applied to the RNAi technology combined with SM1 biocontrol bacteria to control the black wing soil termites. The invention has the characteristics of strong specificity, excellent effect and environmental protection, deepens the physiological function and effect of the OfDrosha of the subterranean termites, also uses the subterranean termites as a new target, develops corresponding immunosuppressants and provides theoretical basis for further improving the biological prevention effect of the subterranean termites.
Drawings
FIG. 1 is a graph of phylogenetic analysis results of Drosha of the subterranean termites;
FIG. 2 is a graph of the expression of the Alternaria nigromaculata OfDrosha in different grades and tissues of Alternaria nigromaculata;
FIG. 3 is a graph of the results of construction of a subterranean termite dsOfDrosha interfering vector, wherein panel A shows cloning of a subterranean termite dsOfDrosha interfering fragment; panel B shows the results of double cleavage verification of the constructed L4440-dsOfDrosha vector;
FIG. 4 is a graph showing the results of the growth of the subterranean termite dsOfDrosha-HT115 and dsGFP-HT115 transgenic strains after sonication;
FIG. 5 is a standard graph of the subterranean termites dsOfDrosha (A) and dsGFP (B);
FIG. 6 is a graph showing the results of expression of OfDrosha at various time points after feeding dsOfDrosha by the subterranean termites;
figure 7 is a graph of the results of silencing OfDrosha of the subterranean termites OfDrosha, results of a bioassay experiment using SM1 for treatment of subterranean termites.
Detailed Description
The invention will be further described with reference to specific embodiments, and advantages and features of the invention will become apparent from the description. However, unless otherwise indicated, all the specific examples described in the examples below were either conventional or were carried out under the conditions recommended by the manufacturer's instructions.
1. Experimental method
The black wing termites were collected from Nanjing, jiangsu province and fed on fermented sawdust in a dark environment at 25+ -1deg.C and 90+ -5% relative humidity. Collected workers, young ants and soldiers are used for grade and tissue specific gene expression analysis. The obtained male and female wedding ants were used for grade and tissue specific gene expression analysis. Serratia marcescens (SM 1) was stored in our laboratory and cultured in fermentation medium. The specific culture method comprises the following steps: 10 mu L of the preserved SM1 bacteria solution is taken and placed into a fermentation medium for culturing for 48 hours at 30 ℃ and 180 rpm/min.
EXAMPLE 1 cloning of the subterranean termite Drosha (OfDrosha) Gene
Total RNA of the black wing termites is extracted, reverse transcription is respectively carried out by referring to the instruction book of PrimeScript 1st Strand cDNA Synthesis Kit kit, and the first step system is as follows:
after the above systems were mixed, the procedure was as follows:
65℃5min
rapidly cooling on ice, and performing a second reaction.
The second step system is as follows:
after the above systems were mixed, the reaction procedure was as follows:
42℃ 60min
95℃ 5s
after the reaction was completed, the mixture was stored in an environment of-20 ℃.
The Primer Premier 5.0 software was used to design the upstream and downstream primers based on the OfDrosha gene sequences in the subterranean black-tail termite transcriptome, the Primer sequences are shown in table one:
PCR amplification of the target Gene:
the cDNA obtained by the reverse transcription was amplified by PCR, and the following was placed on ice:
after the above systems were mixed, the reaction procedure was as follows:
94℃5min
94℃30s,58℃30s,72℃1min30 s (35 cycles)
92℃10min
4℃∞
After the reaction, a part of the PCR product is subjected to gel electrophoresis, observed by a gel imager and photographed and recorded, a part of the product is used for TA cloning and sent to Nanjing qing department Biotechnology Co., ltd for sequencing, and the rest part is stored in an environment of-20 ℃.
Example 2 phylogenetic analysis of subterranean termites with other insects Drosha
The OfDrosha gene was cloned in this study. We studied the relationship between Drosha of Blackwing termites and other insects by constructing phylogenetic trees. The Amino Acid (AA) sequence (OfDrosha) is determined by the NCBI Open Reading Frame (ORF) finder (https:// www.ncbi.nlm.nih.gov/order /). We used each of these genes as a topic to query non-redundant databases (https:// www.ncbi.nlm.nih.gov /) on the NCBI website. MEGAX (version 10.1) was used to analyze multiple amino acid sequence arrangements and construct phylogenetic trees by adjacency (NJ) using 1000 guide replications.
Example 3 expression level of Alternaria nigra OfDrosha
Total RNA from each sample (about 50 mg) was extracted using RNA isolater Total RNA Extraction Reagents and cDNA was synthesized using HiScript IIQ RT SuperMix (R223-01,Vazyme BiotechnologyNanjing,Co, ltd., nanjing, china) according to the manufacturer's instructions. The expression levels of OfDrosha were analyzed by real-time fluorescent quantitative PCR (qRT-PCR), GAPDH and RPS18 as reference genes (table 1). All primers are listed in Table 1. Primers were tested for amplification efficiency using Linreg PCR software (version 2016.1) as described by Ramakers. Grade and tissue specific qRT-PCR detection with 2 -ΔCt Analysis by the method, the rest qRT-PCR detection adopts 2 -ΔΔCt And (5) analyzing by a method.
Example 4 Synthesis of subterranean termites dsofDrosha
The dsRNA primers for Drosha were designed based on the OfDrosha nucleic acid sequence of the subterranean termite species (Table 1). The PCR product obtained was subcloned into the expression vector L4440. The fused expression vector was transformed into a conforming cell, E.coli HT115 (DE 3). The specific method comprises the following steps:
table 1 primers used in the experiments
Note that: the bold letters are cleavage sites.
The cDNA obtained by reverse transcription was amplified by PCR, and the system was prepared as follows on ice:
after the above systems were mixed, the reaction procedure was as follows:
95℃3min
95℃15s,57℃15s,72℃30s (35 cycles)
72℃10min
4℃∞
After the reaction is finished, a part of PCR products are subjected to gel electrophoresis, and are observed and photographed by a gel imager for recording, and a part of products are subjected to gel recovery for subsequent dsRNA expression vector construction.
The purified target fragment and L4440 plasmid were double digested with restriction endonucleases HindIII and XhoI, respectively, while the control plasmid containing green fluorescent protein (Green fluorescent protein, GFP) was double digested with restriction endonucleases SacI and HindIII, as follows:
double enzyme digestion is carried out at 37 ℃ overnight, detection and identification are carried out through 1% agarose gel electrophoresis, and the target fragment and the target vector are purified by using a DNA gel recovery kit respectively. Then, the target fragment and the target vector are connected by using T4DNA ligase at 16 ℃ overnight, and the connection system is as follows:
ligation was completed to obtain a recombinant plasmid containing the fragment of interest, which was transformed into HT115 (DE 3) competent cells, as follows:
(1) HT115 (DE 3) competent cells were removed from-80℃and rapidly inserted into ice, and after the pellet melted, the plasmid of interest was added and gently mixed by hand dialing the bottom of the EP tube, and allowed to stand in ice for 25min.
(2) Water bath at 42 ℃ for 45s, quickly put back in ice and stand for 2min.
(3) To the centrifuge tube, 700. Mu.L of LB sterile medium without antibiotics was added, and resuscitated at 37℃for 60min at 200 rpm.
(4) Centrifuge at 5000rpm for 1min, leave about 50. Mu.L of supernatant gently blow the resuspended pellet and spread on LB solid medium containing tetracycline (concentration 12.5. Mu.g/mL) and ampicillin (concentration 50. Mu.g/mL).
(5) The plates were placed in an incubator at 37℃overnight.
The monoclonal antibody cultured overnight in the culture medium is selected, added into LB sterile culture solution containing tetracycline and ampicillin, cultured at 37 ℃ and 200rpm until turbidity, and the connection product is subjected to double digestion and sequencing identification, and is stored in a refrigerator at-80 ℃ according to the mixing of HT115 bacterial liquid and 50% glycerol according to the ratio of 1:1.
5. Mu.L of HT115 bacteria solution was added to 50mL of sterile LB medium, and tetracycline and ampicillin were added to the medium at final concentrations of 12.5. Mu.g/mL and 75. Mu.g/mL, respectively. After culturing at 37deg.C and 200rpm for 12h, adding again to 50mL of sterile LB culture solution, simultaneously adding the same amount of tetracycline and ampicillin as in the previous step, culturing at 37deg.C and 200rpm to OD 600 IPTG was added at a final concentration of 0.4-0.6 to a final concentration of 0.8mM, and the culture was continued at 37℃and 200rpm for 4 hours, at which time the dsRNA was already expressed in a large amount in the bacterial liquid to extract RNA.
EXAMPLE 5 preparation of dsRNA by ultrasonic inactivation of engineering Strain dsOfDrosha-HT115
Adding 10 μl of preserved dsOfDrosha-HT115 bacterial liquid into 50mL of LB liquid medium, adding ampicillin and tetracycline into the LB liquid medium to obtain final concentrations of 75 μg/mL and 12.5 μg/mL, shake culturing at 37deg.C for 24 hr, adding 1mL of bacterial liquid into 50mL of LB liquid medium again, shake culturing at 37deg.C to OD 600 400 μl of IPTG was added to a final concentration of 0.8mM when the concentration was between 0.4 and 0.6, and the bacterial suspension was cultured at 37 ℃ for 4 hours with shaking. Using ultrasonic treatment method to kill dsRNA-HT115 engineering strain and destroy cell wall and cell membrane of bacteria,promoting the release of dsRNA. Specifically, 8mL of dsOfDrosha-HT115 bacterial liquid was centrifuged at 8000rpm for 5min, the supernatant was removed, and 5mL of DEPC water was added and mixed well. The bacterial suspension was disrupted using an ultrasonic cell disrupter with a power of 50% and a start of 3s and stop of 6s. mu.L of the bacterial liquid was aspirated every 20min and then plated on LB medium (containing 100. Mu.g/ml ampicillin and 12.5. Mu.g/ml tetracycline) for 24 hours before observation.
Example 6 interference efficiency of subterranean termites dsofDrosha
Design of experiment includes ddH 2 Group O, dsGFP, and dsOfDrosha treated groups. The black wing termites were fed with filter paper in a 5cm dish and ddH was used 2 O (negative control), 400. Mu.L dsGFP (positive control) or 400. Mu.L dsOfDrosha (treatment group) [ ddH ] 2 O, dsRNA with Nel blue (10% w/v), respectively]The workers were collected at 3, 6, 12 and 24 hours and the expression of these genes was detected by qRT-PCR. Experiments were performed independently in triplicate.
Example 7 sensitivity assay to SM1 after silencing of the Alternaria nigromaculata OfDrosha Gene
In this experiment, a quantity of subterranean termites from the Solanum nigrum was transferred to a medium containing 400. Mu.L ddH 2 O, dsGFP and dsOfDrosha [ ddH ] 2 O, dsRNA with Nel blue (10% w/v), respectively]Is treated in a petri dish for 12 hours, and then ddH is added 2 The O, dsGFP, dsOfDrosha treated workers were divided into two groups (fermentation medium treated and SM1 treated groups), respectively. One microliter of fermentation medium was dropped onto the forechest of each control workers, and 1. Mu.L of SM1 (1.8X10) 10 CFU/mL) was dropped onto the chest backboard of each treatment worker. Each repetition consisted of 20 workers and each treatment was repeated 3 times. Observation was stopped every 2h until one of the conditions appeared: (1) The mortality rate of the fermentation medium treated group was lower than 20% while all members of the SM1 treated group died. (2) Regardless of mortality in the SM1 treated group, mortality in the fermented media group exceeded 20%.
2. Data analysis
Collected data were analyzed by analysis of variance (ANOVA) using intat software (GraphPad, san Diego, CA, USA). Significant differences between the two samples were compared using a two-tailed unpaired t-test. The statistical significance of the multiple sample comparisons was determined using one-way anova followed by Tukey's multiple comparisons.
3. Results and analysis
1. Phylogenetic analysis of black-wing subterranean termites and other insects Drosha
Blast analysis is performed on the amino acid sequence of Drosha of the subterranean termites, and the fact that the amino acid sequence of Drosha of the subterranean termites has high similarity with the homologous sequences of other insects is found. To study the phylogenetic relationship of Drosha of the subterranean termites, we constructed a phylogenetic tree of the Drosha amino acid sequence of subterranean termites with other insect species. The AA sequences of the black-winged soil termites Drosha are clustered with those of Zootermopsis nevadensis and Cryptotermes secundus (as shown in fig. 1, wherein specific branches of coleoptera, lepidoptera, orthoptera, hymenoptera and diptera Drosha are represented in different colors).
2. Specific expression of ofDrosha in the grades and tissues of subterranean termites
Gene expression analysis shows that the expression level of OfDrosha in each grade and tissue of the subterranean termite is different. In workers and soldiers, the expression level of OfDrosha was significantly higher than that of larvae, female wedding ants and male wedding ants (fig. 2). Furthermore, our findings indicate that OfDrosha is expressed in different tissues of different populations, including haemolymph, gut, head and leg. The expression level of OfDrosha in blood stranguria was highest, followed by intestinal tract, and the lowest expression level was head and leg. ( As shown in fig. 2, the grades include workers, soldiers, larvae, female wedding ants, and male wedding ants. Tissues include haemolymph, intestine, head, skin and feet. Data are expressed as mean ± SD of three replicates. The same letters on the error bars indicate that there is no significant difference in OfDrosha expression (P > 0.05). )
3. Construction of a Blacker Solanum nigrum dsOfDrosha interference vector
We obtained a DNA band of 546bp dsOfDrosha by cloning (FIG. 3A). Then we constructed the correct sequence for sequencing onto the L4440 expression vector, confirming that dsOfDrosha was successfully constructed by double enzyme validation (fig. 3B).
4. Inactivation of dsOfDrosha-HT115 and dsGFP-HT115 and drawing of standard curves
The bacterial liquid was sonicated using a cell disrupter, and samples were collected every 30min, and we found that plating was performed on the bacterial liquid after the sonication, and the number of colonies was continuously reduced with the extension of disruption time, and colonies were no longer present on the plates after 2.5h and 3h of treatment (FIG. 4). We performed subsequent experiments using the treatment fluid at this point.
The logarithm of the four gradient concentrations was plotted against the corresponding CT values, and the standard curve for dsOfDrosha was calculated as y= -2.5223x+16.648 (R 2 = 0.9319) (fig. 5A), the standard curve of dsGFP established y= -2.0459x+16.658 (R 2 =0.9624) (fig. 5B).
5. Determination of interference efficiency of the subterranean termites dsofDrosha
20 workers were grouped into petri dishes (diameter 7 cm) with dry filter paper, which was treated with 400. Mu.L dsOfDrosha and nile (1% w/v) with dsGFP and nile (1% w/v) as positive controls and DEPC water and nile (1% w/v) as negative controls. Termites were placed in a dark environment and harvested at 3, 6, 12 and 24 hours. Then total RNA of termite workers received at different treatment times was extracted, primers were designed outside the dsRNA interference area (Table 1, below), and qRT-PCR was used to detect the expression level of the termite OfDrosha gene at different treatment times. By 2 -ΔΔCT The qRT-PCR data was analyzed.
After dsodrosha treatment, samples were collected at 3, 6, 12 and 24 hours, respectively, and the expression of the odrosha gene was detected by qRT-PCR, and we found that the expression of the odrosha gene was inhibited in all time periods, and the transcript level of the odrosha gene was decreased by 23.53,51.39,81.32and 74.41% at 3, 6, 12 and 24 hours, respectively. ( As shown in fig. 6, wherein the data are expressed as mean ± SD of three replicates. The same letters on the error bars indicate that there is no significant difference in the expression of OfDrosha (P > 0.05). )
6. Effect of dsOfDrosha on SM1 on subterranean termite virulence
Treatment of subterranean termites with SM1 after silencing OfDrosha gene showed that at 20h, the mortality rate (7.5%) of dsOfDrosha-SM1 group was significantly higher than that of the other treatment groups; at 40h, the mortality rate of dsOfDrosha-SM1 group was 28.75%, significantly higher than that of the other treatment groups; at 60h, the mortality rate of dsOfDrosha-SM1 group was 80% and significantly higher than that of the other treatment groups; the results of the survival curves showed that the survival rate of dsofDrosha-SM1 group was lower than that of the other SM1 treated groups (CK-SM 1 group, dsGFP-SM1 group), and that the survival rate of SM1 treated groups (CK-SM 1, dsGFP-SM1, dsOfDrosha-SM 1) was lower than that of the control groups (CK group and dsGFP group). ( As shown in fig. 7, wherein fig. 7A is mortality of the black-winged soil termites within 20h after silencing OfDrosha gene with SM1 treatment; FIG. 7B is mortality of subterranean termites within 40h after silencing the OfDrosha gene by SM1 treatment; FIG. 7C is mortality of the subterranean termites within 60h after silencing the OfDrosha gene by SM1 treatment; FIG. 7D is the survival rate of subterranean termites treated with SM1 after silencing the OfDrosha gene. Data are expressed as mean ± SD of three replicates. In these figures, the different letters represent a significant difference in the mortality rate of the black wing subterranean termites (P < 0.05). )
The result shows that after the disturbance ofDrosha, the death rate of the termite can be obviously improved by the SM1 re-infection of the termite with the black wing soil: feeding the black-winged subterranean termites with dsOfDrosha obtained by using the inactivated engineering strain can silence the expression of the OfDrosha, and silencing the OfDrosha gene of the black-winged subterranean termites can enhance the insecticidal effect of SM 1.
Claims (8)
1. The gene of the Alternaria nigra OfDrosha is characterized in that the nucleotide sequence is shown as SEQ ID No. 0:1.
2. Use of the OfDrosha gene of the black-fin soil termite according to claim 1 for reducing the resistance of termite to pathogenic bacteria.
3. The use according to claim 2, wherein the pathogenic bacteria are serratia marcescens.
4. A subterranean termite OfDrosha gene dsRNA, characterized in that it is obtained from a subterranean termite OfDrosha gene according to any one of claims 1-3.
5. A method for controlling black-wing subterranean termites, which is characterized in that after dsrnas are obtained from the OfDrosha genes of any one of claims 1-3, the black-wing subterranean termites are treated for 6-24 hours by the dsrnas, and then are treated by serratia marcescens.
The application of the OfDrosha gene dsRNA in improving the effect of Serratia marcescens in preventing and controlling the subterranean termites is characterized in that the OfDrosha gene dsRNA capable of improving the effect of Serratia marcescens in preventing and controlling the subterranean termites consists of a nucleotide sequence shown as SEQ ID N0:1, and the preparation method of the OfDrosha gene dsRNA is as follows:
(1) Extracting total RNA in the black wing soil termite body, and obtaining termite cDNA library through reverse transcription;
(2) Using termite cDNA as a template, amplifying the OfDrosha gene fragment by using an OfDrosha specific primer, and separating and purifying the OfDrosha gene fragment by agarose gel electrophoresis, wherein the OfDrosha specific primer is as follows: an upstream primer (5 '-3') ATGTGGTACAATGACTCGGGAG, and a downstream primer (5 '-3') TTATTTCTTGCCTGCAGACACTT;
(3) Obtaining an OfDrosha plasmid containing a target gene OfDrosha through TA cloning;
(4) Amplifying by using cDNA as a template and using a specific primer to obtain a dsRNA template, wherein the sequence of the upstream primer (5 '-3') is CCCAAGCTTGTGACCGTAGGATTCATTACATGAA, and the sequence of the downstream primer (5 '-3') is CCGCTCGAGTGGTGAGATTTTGCAGCAGC;
(5) The fused expression vector is transformed into qualified cell escherichia coli HT115 (DE 3) to obtain dsRNA-HT115 engineering strain;
(6) Killing dsRNA-HT115 engineering strains by using an ultrasonic treatment method, and simultaneously destroying cell walls and cell membranes of bacteria to promote the release of dsRNA;
(7) After the dsRNA obtained above is fed to the black wing soil termites through filter paper, serratia marcescens is dripped on the chest backboard of the worker termite.
7. The use of claim 6, wherein the dsRNA is further treated with serratia marcescens after 6-24 hours of treatment with subterranean termites.
8. The use of claim 7, wherein the dsRNA is treated with serratia marcescens 6 hours later than treatment with serratia nigra.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311496611.5A CN117431261A (en) | 2023-11-09 | 2023-11-09 | OfDrosha gene dsRNA capable of improving termite control effect of Serratia marcescens |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311496611.5A CN117431261A (en) | 2023-11-09 | 2023-11-09 | OfDrosha gene dsRNA capable of improving termite control effect of Serratia marcescens |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117431261A true CN117431261A (en) | 2024-01-23 |
Family
ID=89558205
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311496611.5A Pending CN117431261A (en) | 2023-11-09 | 2023-11-09 | OfDrosha gene dsRNA capable of improving termite control effect of Serratia marcescens |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117431261A (en) |
-
2023
- 2023-11-09 CN CN202311496611.5A patent/CN117431261A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111187726B (en) | Rice blast bactericide prepared by using lysine-resistant bacillus borreliensis as chassis cells | |
CN110468137B (en) | Himalayan twenty eight star ladybug high-lethal gene and application thereof in preventing and treating ladybug | |
CN113106108A (en) | Double-stranded nucleic acid Dicer-1 dsRNA (double-stranded ribonucleic acid) for enhancing biocontrol bacterium and termite killing effect | |
CN114478735B (en) | High-mortality dsRNA of aphids and application of high-mortality dsRNA in aphid control | |
CN110759983A (en) | Recombinant fungus expressed by targeted silent pest pattern recognition protein GNBP3 gene and application thereof in pest control | |
CN111748533B (en) | Termite SelT gene and application of dsRNA (double-stranded ribonucleic acid) thereof in combination with metarhizium anisopliae in termite control | |
CN116732042B (en) | Bemisia tabaci Gawky gene and application thereof in biological control of Bemisia tabaci | |
AU2016291813B2 (en) | Transgenic microalgae and use thereof as a feed for delivery of interfering RNA molecules | |
CN109136101B (en) | Fungus strain and application thereof | |
CN1459506A (en) | Recombination expression and application of Chinese prawn antibacterial peptide gene | |
CN117431261A (en) | OfDrosha gene dsRNA capable of improving termite control effect of Serratia marcescens | |
CN113621620B (en) | Gene with function of regulating and controlling immunity of plutella xylostella and preparation method and application thereof | |
CN115927091A (en) | Burkholderia BWT1.3 for antagonizing various plant pathogenic bacteria and application thereof | |
CN111378665B (en) | Interference sequence of serpin5 gene of locusta migratoria manilensis and application thereof | |
CN110951730B (en) | dsRNA of cryptopteris viridis V-ATPase-A gene, artificial feed and application thereof | |
CN117417918A (en) | Function of Alternaria nigromaculata OfDicer1 and application of Alternaria nigromaculata OfDicer1 in termite control | |
CN110592044B (en) | Protein kinase Fused coding gene and application thereof in preventing and treating diamond back moth | |
CN118086290A (en) | Subterranean termite OfArgonaute gene and application thereof | |
CN106367428A (en) | Lygus lucorum V-ATPase-D gene cDNA and application thereof | |
CN113881679B (en) | miR-71-5 mimic for enhancing termite killing effect of metarhizium anisopliae | |
CN116426541B (en) | Target gene segment, dsRNA and nano pesticide composition for preventing and treating verticillium wilt of crops | |
CN109913480A (en) | A kind of locust uridine diphosphate glucuronatetransferase gene and its application | |
CN111647599B (en) | Interference sequence of locusta migratoria serpin1 gene and application thereof | |
CN118726369A (en) | Double-stranded nucleic acid Tsf dsRNA for enhancing biological control bacteria and termite killing effect | |
CN113755530B (en) | Application of knocking out or silencing bee hive beetle odor binding protein gene 1 in prevention and treatment of bee hive beetles |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |